The authors should provide sample size estimation to demonstrate that given their sample size of 557 patients (taken into the account of loss to follow-up), there will be sufficient statistical power for the evaluation of their primary and secondary outcomes.
Since Cox regression will be performed, please indicate that the proportional hazards assumption will be tested.
Please mention how missing data from explanatory variables will be handled.
The authors should mention in the Statistical Analysis section that possible interactions between variables (defined a priori, such as age, sex and others that are of interest) will be examined, and how interactions will be treated if present.
Please specify the statistical test planned to be used for the analysis of the secondary outcomes.
The authors indicated that a clinical scoring system will be developed. Please outline the method to be used for internal validation.
The authors may want to check the reference list to make sure that it is up-to-date. For example, there is an update version for the reference no. 4. (El-Serag HB, Sweet S, Winchester CC, Dent J. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2014; 63(6):871-880. doi:10.1136 /gutjnl-2012 .
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GENERAL COMMENTS
Thank you for the opportunity to review this protocol. My comments are as follows:
Abstract: Line 16, should this be quality of life post surgery?
Introduction: Page 6, line 21 "where" should be "were". Otherwise introduction provides appropriate background.
Methods: Page 7, line 18. Does the n=557 refer to the number of patients who have undergone surgery? If this is the case it perhaps should go after "laparoscopic anti-reflux surgery" on line 14 for clarity. It is also assumed that this number has been checked already with hospital data to ensure that the population is large enough?
Page 8. How will the quality of life follow up information be obtained? Online, postal survey? This requires some clarification.
Page 8 Registries section, first sentence should be "All Danish inhabitants..."
Outcomes: Appropriate
Statistical analysis: Appropriate.
Ethics and patient and public involvement statement: Appropriate.
VERSION 1 -AUTHOR RESPONSE

Reviewer 2
Would not necessarily agree with the authors that the breakdown of a fundoplication should be the biggest complication of laparoscopic fundoplication, as this should more be in line with failure of surgery, at least in the short-term.
We have specified, that disruption of the fundoplication is not the most preeminent complication of laparoscopic fundoplication, but only one among several possible complications As well, arguably the use of PPI >60 days in a year after the surgery may not necessarily qualify as a failure, without some objective assessment of Esoph pH testing. Many pts get started on PPIs without any evidence of pathologic esoph acid exposure post op. We have included the need of at least two separate scripts when redeeming PPI postoperatively. It is not possible for us to investigate all patients using oesophageal pH-testing. We are aware of this possible overestimation of recurrence of reflux disease and address this by enquiring the patients who prescribed the anti-reflux treatment and why. We will also address this possible shortcoming in our future papers on the study.
Reviewer: 3
The authors should provide sample size estimation to demonstrate that given their sample size of 557 patients (taken into the account of loss to follow-up), there will be sufficient statistical power for the evaluation of their primary and secondary outcomes. Power calculation has now been included in the manuscript taking into account possible loss to follow-up Since Cox regression will be performed, please indicate that the proportional hazards assumption will be tested. 
GENERAL COMMENTS
The authors have adequately addressed my comments raised in the previous round except regarding the statistical power calculation. The current calculation appeared to be based on a comparison of two proportions. It is not clear whether the two proportions (15% and 25%) for the failure rates were obtained from the authors' previous studies or from literature review, but more importantly, a power calculation for survival analysis should be used instead of that for comparing proportions.
VERSION 2 -AUTHOR RESPONSE Reviewer 3:
-The authors have adequately addressed my comments raised in the previous round except regarding the statistical power calculation. The current calculation appeared to be based on a comparison of two proportions. It is not clear whether the two proportions (15% and 25%) for the failure rates were obtained from the authors' previous studies or from literature review, but more importantly, a power calculation for survival analysis should be used instead of that for comparing proportions.
We have completely revised our power calculation to include an appropriate power calculation for survival analysis and included references for the assumed failure rate. The assumed failure rate is based on national Danish data previously published. As the sample size is fixed in our study, we demonstrate the possible effect size of our study.
